...
首页> 外文期刊>Environmental toxicology >Latex of Euphorbia antiquorum-Induced S-Phase Arrest via Active ATM Kinase and MAPK Pathways in Human Cervical Cancer HeLa Cells
【24h】

Latex of Euphorbia antiquorum-Induced S-Phase Arrest via Active ATM Kinase and MAPK Pathways in Human Cervical Cancer HeLa Cells

机译:大戟抗法定人数诱导的胶乳通过人宫颈癌HeLa细胞中的主动ATM激酶和MAPK途径被阻滞

获取原文
获取原文并翻译 | 示例
           

摘要

Latex of Euphorbia antiquorum (EA) has demonstrated great chemotherapeutic potential for cancer. However, the mechanisms of anti-proliferation of EA on cancer cell remain to be further investigated. The purpose of this study was to explore the influence of EA in human cervical cancer cells. Here, the cell cycle distribution by flow cytometry was examined and the protein expression by the western blotting methods was analyzed. From the cytometric results it was shown that EA-induced S-phase arrest in a concentration manner both in human cervical cancer HeLa and CaSki cells. According the western blot results it was illustrated that EA could downregulate early cyclin E1-Cdk2; and cyclin A-Cdc2 provides a significant additional quantity of S-phase promotion, that in turn promoted the expression of p21~(waf1/cip1) and p27~(kip1) which were the inhibitors in the complex of cyclin A and Cdc2 that led to cell cycle arrest. Moreover, EA promoted the activation of ataxia telangiectasia mutated (ATM) and check-point kinase-2 (Chk2); however, it negatively regulated the expression of Topoisomerases Ⅰ and Ⅱ, Cdc25A, and Cdc25C signaling. Caffeine, an ATM/ATR inhibitor significantly reversed EA downregulation in the levels of Cdc25A. Furthermore, JNK inhibitor SP600125 and p38 MAPK inhibitor SB203580 both could reverse the EA upregulation of the protein of Chk2 level, significantly. This study, therefore, revealed that EA could downregulate topoisomerase, and activate ATM kinase, which then induce parallel Chk 1/2 and MAPK signaling pathways to promote the degradation of Cdc25A to induced S-phase arrest in human cervical cancer HeLa cells.
机译:大戟抗定乳(EA)的乳胶已显示出巨大的化学治疗潜力。然而,EA对癌细胞的抗增殖机制仍有待进一步研究。这项研究的目的是探讨EA对人宫颈癌细胞的影响。在这里,通过流式细胞术检查细胞周期分布,并通过蛋白质印迹法分析蛋白质表达。从细胞计数结果表明,EA诱导的S期停滞在人类宫颈癌HeLa和CaSki细胞中都以集中的方式发生。根据蛋白质印迹结果,可以证明EA可以下调早期细胞周期蛋白E1-Cdk2。细胞周期蛋白A-Cdc2提供了更多的S期促进作用,从而促进了细胞周期蛋白A和Cdc2的复合物中的抑制剂p21〜(waf1 / cip1)和p27〜(kip1)的表达。细胞周期停滞。此外,EA促进了共济失调性毛细血管扩张突变(ATM)和检查点激酶2(Chk2)的激活。然而,它负调控拓扑异构酶Ⅰ和Ⅱ,Cdc25A和Cdc25C信号的表达。咖啡因,一种ATM / ATR抑制剂,可显着逆转EA在Cdc25A中的下调。此外,JNK抑制剂SP600125和p38 MAPK抑制剂SB203580均可显着逆转EA对Chk2水平蛋白的上调。因此,这项研究表明,EA可以下调拓扑异构酶,并激活ATM激酶,然后诱导平行的Chk 1/2和MAPK信号通路,从而促进Cdc25A降解,从而诱导人宫颈癌HeLa细胞S期停滞。

著录项

  • 来源
    《Environmental toxicology》 |2015年第10期|1205-1215|共11页
  • 作者单位

    Department of Pharmacology, China Medical University, Taichung, Taiwan;

    School of Pharmacy, China Medical University, Taichung, Taiwan;

    Department of Pharmacology, China Medical University, Taichung, Taiwan;

    Department of Pharmacology, China Medical University, Taichung, Taiwan;

    Tsuzuki Institute for Traditional Medicine, College of Pharmacy, China Medical University, Taichung, Taiwan;

    Department of Pharmacology, School of Medicine, Geriatric Research, Education and Clinical Center, VA Medical Center, University of Minnesota, Minneapolis, Minnesota;

    Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei 112, Taiwan,Department of Restaurant, Hotel and Institutional Management, Fu-Jen Catholic University, New Taipei 242, Taiwan;

    Department of Biological Science and Technology, China Medical University, Taichung 404, Taiwan,Department of Biotechnology, Asia University, Taichung 413, Taiwan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    EA; cervical cancer; cell cycle; Chk1/2; Cdc25C; Cdc2; topoisomerase Ⅰ; ATM/ATR;

    机译:EA;宫颈癌;细胞周期;Chk1 / 2;Cdc25C;Cdc2;拓扑异构酶Ⅰ;ATM / ATR;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号